Recent advances in the chemotherapy of tuberculosis

Pandit, Padmakar; Tiwari, Smita

doi:10.1016/s0973-3698(11)60039-3

Cited by 1 publication

(1 citation statement)

References 24 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…1 Nowadays, TB can be treated by several drugs, the main ones being isoniazid, rifampin, ethambutol and pyrazinamide. [2][3][4][5][6] Also known as isocotinylhydrazine (INH), 7 isoniazid is a first-line anti-TB prodrug that has been used since 1952 8 as the most potent bactericidal. 5,6 Upon its entry into the cell, INH is activated by the calase-perozidase (KatG) enzyme.…”

Section: Introductionmentioning

confidence: 99%

The quantum biophysics of the isoniazid adduct NADH binding to its InhA reductase target

et al. 2014

View full text Add to dashboard Cite

Mycobacterium tuberculosis (MT) is the aerobic bacterium responsible for the infectious disease tuberculosis (TB). Among the several anti-TB drugs, the first-line anti-TB prodrug isoniazid (INH) has the most potent bactericidal activity. After INH activation by the catalase-peroxidase (KatG) enzyme, the isonicotinic acyl-NADH (INADH) complex is created, which interacts with the enoyl-acyl carrier protein reductase (InhA) active site inhibiting the MT activity. However, mutations in the InhA gene can reduce the InhA-INADH affinity, thus decreasing the large benefits of INH in TB treatment. To provide a deeper understanding of the mechanisms responsible for the anti-TB INADH activity, we study the InhA-INADH interaction using a density functional theory (DFT) quantum mechanical approach. The interaction energies are calculated using the molecular fractionation with the conjugate caps (MFCC) scheme, which allows the quantification of, through the residues' binding energy, their individual role in the binding pocket, as well as the other relevant residues near the InhA binding site. Besides the importance of amino acid residues with charged lateral chains, our results unveil the role of structural water molecules in the InhA-INADH binding energy. Among all the amino acids in the InhA, we highlight I21 and S94 due to their relevance to the INADH activity after specific InhA mutations. I21 and S94 are strongly bonded to the INADH with an energy of À33.4 kcal mol À1 and À23.1 kcal mol À1 , respectively. These values and the positions of I21 and S94 residues relative to the INADH indicate that the ribose of adenine and pyrophosphate groups in INADH strongly influence the total INADH-InhA interaction and consequently the INH anti-TB activity. All reported results contribute to a deeper understanding of the INADH-InhA binding that can be explored in the design of new antitubercular drugs.

show abstract